ZANNES MARIA (President, CEO) exercised options at BIOAFFINITY TECHNOLOGIES, INC.
Option exercise — a mechanical event triggered by vesting or expiry. Not a discretionary conviction trade.
M · 1 exercise
Filed: 4/24/2024ACC: 0001493152-24-015791
DirectorOfficer· President, CEO
Since Aug 2022
-28.26K
Net shares
Net seller
$74.9K
Total sold
0
Open market trades
0B · 0S
3
Total transactions
64.85K acquired · 93.11K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+64.85K
Price / share
$1.16
Trade value
$75.22K
% of position
39.4%
4/8/2024
164.66K→229.51K
Common Stock
Direct
Shares
−28.26K
Price / share
$2.65
Trade value
$74.90K
% of position
12.3%
4/8/2024
229.51K→201.24K
Total
Net shares
+36.58K
Net value
$324.08
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 4/8/2024 | M · Option Exercise | +64.85K | $1.16 | $75.22K | 39.4% | 164.66K | 229.51K |
| Common Stock Direct | 4/8/2024 | F · Tax Withholding | −28.26K | $2.65 | $74.90K | 12.3% | 229.51K | 201.24K |
| Total | +36.58K | $324.08 | ||||||
Derivative Transactions1
Stock Option (right to buy)
Direct
Converts to
Common Stock
64.85K shares
Shares
−64.85K
Strike price
1.16
Held after
0.00
Exercisable
—
4/8/2024
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (right to buy) Direct | Common Stock64.85K shares | 4/8/2024 | M · Option Exercise | −64.85K | 1.16 | — | 0.00 |